Bristol-Myers Squibb acquires Celgene for $74bn, deepening strength in oncology
Drug Discovery Tools
- Drug Discovery Tools
- Includes Contract
- Full Acquisition
- Payment Includes Cash
- Includes Earnout
- Payment Includes Stock
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.